Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;23(2):174.
doi: 10.3892/etm.2021.11097. Epub 2021 Dec 28.

Continuous glucose monitoring devices: A brief presentation (Review)

Doina Andrada Mihai  1   2 , Diana Simona Stefan  1   2 , Daniela Stegaru  1   2 , Georgiana Elena Bernea  2 , Ileana Adela Vacaroiu  3   4 , Toma Papacocea  5 , Mircea Ovidiu Denis Lupușoru  6 , Adriana Elena Nica  7 , Ovidiu Stiru  8   9 , Dorin Dragos  10   11 , Octavian Gabriel Olaru  12
Affiliations
Review

Continuous glucose monitoring devices: A brief presentation (Review)

Doina Andrada Mihai et al. Exp Ther Med. 2022 Feb.

Abstract

As diabetes prevalence is continuously increasing, better management is needed to achieve blood glucose control, in order to prevent complications and lessen the burden of this disease. Since the first measurement of glycosuria at the beginning of the 1900s', huge advances were made in monitoring glycemia. Continuous glucose monitoring systems revolutionized diabetes management, especially for patients with type 1 diabetes. Avoiding glycemic variability and maintaining optimal glycemic control is crucial for the evolution of patients with type 1 diabetes. The usefulness of glycemic monitoring devices can be extended to patients with type 2 diabetes. It is also important to note that in those patients at risk of developing high glycemic variability (e.g. patients with advanced chronic kidney disease), continuous glycemic monitoring may improve their prognosis. These monitoring systems can be classified according to the analytical method, the degree of invasiveness, the data availability and the mode of usage. The technology is constantly improving in bioanalytical performance, biocompatibility, length of wearing time, safety and clinical features. The aim of this review was to briefly present the main characteristics of glucose biosensors, glucose monitoring systems and their clinically utility.

Keywords: biosensors; continuous glucose monitoring systems; diabetes; glucose detection technologies; polymers.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. International Diabetes Federation. IDF diabetes atlas, 9th edition. Brussels, Belgium: 2019. Available from: https://www.diabetesatlas.org. https://www.diabetesatlas.org/en/. Accessed Jun 2021.
    1. Stroescu AE, Tanasescu MD, Diaconescu A, Raducu L, Constantin AM, Balan DG, Tarmure V, Ionescu D. Cardiovascular comorbidities, inflammation and serum albumin levels in a group of hemodialysis patients. Rev Chim. 2018;69:926–929.
    1. Stroescu AE, Tanasescu MD, Diaconescu A, Raducu L, Balan DG, Mihai A, Tanase M, Stanescu II, Ionescu D. Diabetic nephropathy: A concise assessment of the causes, risk factors and implications in diabetic patients. Rev Chim. 2018;69:3118–3121.
    1. Mandita A, Timofte D, Balcangiu-Stroescu AE, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dragos D, Cosconel CI, Stoicescu SM, Ionescu D. Treatment of high blood pressure in patients with chronic renal disease. Rev Chim. 2019;70:993–995.
    1. Timofte D, Mandita A, Balcangiu-Stroescu A, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dragos D, Cosconel CI, Stoicescu SM, Ionescu D. Hyperuricemia and cardiovascular diseases clinical and paraclinical correlations. Rev Chim. 2019;70:1045–1046.